Protagonist Therapeutics, Inc. (PTGX)
84.96
+3.60
(+4.42%)
USD |
NASDAQ |
Jan 14, 15:51
Protagonist Therapeutics Price: 84.96 for Jan. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 218.46 |
| ADMA Biologics, Inc. | 18.10 |
| Bristol Myers Squibb Co. | 56.72 |
| MannKind Corp. | 5.575 |
| Regeneron Pharmaceuticals, Inc. | 754.43 |
Price Related Metrics
| PE Ratio | 134.15 |
| PS Ratio | 26.06 |
| Price to Book Value | 8.229 |
| Price to Free Cash Flow | 85.56 |
| Earnings Yield | 0.75% |
| Market Cap | 5.311B |
| Operating PE Ratio | 286.79 |
| Normalized PE Ratio | 134.15 |